SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-187318
Filing Date
2023-07-14
Accepted
2023-07-14 16:52:32
Documents
18
Period of Report
2023-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d651936d8k.htm   iXBRL 8-K 64354
2 EX-2.1 d651936dex21.htm EX-2.1 575612
3 EX-10.1 d651936dex101.htm EX-10.1 49993
4 EX-10.2 d651936dex102.htm EX-10.2 48805
5 EX-10.3 d651936dex103.htm EX-10.3 35154
6 EX-10.4 d651936dex104.htm EX-10.4 33944
7 EX-10.5 d651936dex105.htm EX-10.5 149146
  Complete submission text file 0001193125-23-187318.txt   1309388

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA freq-20230714.xsd EX-101.SCH 2851
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20230714_lab.xml EX-101.LAB 18738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20230714_pre.xml EX-101.PRE 11708
12 EXTRACTED XBRL INSTANCE DOCUMENT d651936d8k_htm.xml XML 3470
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 231089622
SIC: 2834 Pharmaceutical Preparations